Health Canada Authorizes Moderna’s Omicron-Targeting Bivalent COVID-19 Vaccine in Children & Adolescents (6-17 Years)
The recommendation is based on clinical data for Moderna's bivalent Omicron-targeting COVID-19 vaccine, mRNA.1273.214Moderna's bivalent Omicron-targeting COVID-19 vaccines (mRNA.1273.214 (BA.1) & mRNA.1273.222 (BA.4/5)) are currently...